The U.S. government on Tuesday will start distributing 30,000 doses of an experimental antibody drug to fight COVID-19.

The drug is the same one President Trump received last month.

The Food and Drug Administration agreed to allow emergency use of the drug, made by Regeneron Pharmaceuticals Inc., for people with mild to moderate symptoms who are at high risk of developing serious illness because of their age or other medical conditions.

It’s not authorized for use in sicker, hospitalized patients or those who need extra oxygen.

The emergency authorization allows limited use of a drug while studies continue to test its safety and effectiveness. (AP) 

 

 

Â